Most stable sample size determination in clinical trials

被引:0
|
作者
Ali Karimnezhad
Ahmad Parsian
机构
[1] K. N. Toosi University of Technology,Department of Statistics and Computer Science
[2] University of Tehran,School of Mathematics, Statistics and Computer Science
来源
关键词
Bayesian robustness; Normal model; Prior uncertainty; Posterior function; Sensitivity analysis;
D O I
暂无
中图分类号
学科分类号
摘要
This paper is devoted to robust Bayes sample size determination under the quadratic loss function. The idea behind the proposed approach is that the smaller a chosen posterior functional, the more robust the posterior inference. Such desired posterior functional has been taken, in the literature, as the range of posterior mean over a class of priors but we show that dealing with the posterior mean is not the only method leading to an optimal sample size. To provide an alternative approach, we propose implementing most stable rules into the context of sample size determination. We discuss properties of the desired most stable estimate and provide some examples in the normal model. We then compare the proposed approach with that of a recent global robustness study from both numerical and theoretical aspects. We illustrate the practical utility of our proposed method by analyzing a real data set.
引用
收藏
页码:437 / 454
页数:17
相关论文
共 50 条
  • [21] A behavioural Bayes approach for sample size determination in cluster randomized clinical trials
    Kikuchi, Takashi
    Gittins, John
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2010, 59 : 875 - 888
  • [22] Robust Bayesian sample size determination for avoiding the range of equivalence in clinical trials
    Brutti, Pierpaolo
    De Santis, Fulvio
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2008, 138 (06) : 1577 - 1591
  • [23] INTRODUCTION TO SAMPLE-SIZE DETERMINATION AND POWER ANALYSIS FOR CLINICAL-TRIALS
    LACHIN, JM
    CONTROLLED CLINICAL TRIALS, 1981, 2 (02): : 93 - 113
  • [24] A Bayesian cost-benefit approach to the determination of sample size in clinical trials
    Kikuchi, Takashi
    Pezeshk, Hamid
    Gittins, John
    STATISTICS IN MEDICINE, 2008, 27 (01) : 68 - 82
  • [25] On Cost Effectiveness and Sample Size in Clinical Trials
    Augustinus A. M. Hart
    Marcel G. W. Dijkgraaf
    PharmacoEconomics, 2004, 22 : 685 - 688
  • [26] Sample size and clinical trials in pediatric resuscitation
    Edmunds, Katherine
    Zhang, Yin
    Kerrey, Benjamin T.
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2021, 2 (04)
  • [27] Lower sample size requirements for clinical trials studying diary symptoms in OAB patients: Use of the overactive bladder symptom composite score for sample size determination in clinical trials
    Harnett, M
    Sandage, B
    Schwiderski, U
    Sabounjian, L
    Harnett, K
    NEUROUROLOGY AND URODYNAMICS, 2005, 24 (5-6) : 573 - 574
  • [28] The proper sample size in clinical orthopedic trials
    Brocai, DRC
    Lukoschek, M
    Hartmann, M
    Loew, M
    ORTHOPADE, 1998, 27 (05): : 301 - 304
  • [29] An introduction to sample size calculations in clinical trials
    Accordini, Simone
    EPIDEMIOLOGIA E PSICHIATRIA SOCIALE-AN INTERNATIONAL JOURNAL FOR EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES, 2007, 16 (04): : 299 - 301
  • [30] On cost effectiveness and sample size in clinical trials
    Dijkgraaf, MGW
    PHARMACOECONOMICS, 2004, 22 (10) : 685 - 688